RMP-A03 ocular suspension

RMP-A03 · Suzhou Raymon Pharmaceuticals Company, Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RMP-A03 ocular suspension, covering 2024-12-06 to 2026-06-05. Get the full timeline:

Most recent: Clinical Trial Results: RMP-A03 Ocular Suspension in Patients With Pterygium [Phase 2]